FRAMINGHAM, Mass., Nov. 30 /PRNewswire-FirstCall/ -- Saliva Diagnostic Systems, Inc., today announced the appointment of D. Bruce Pattison and Richard H. Woodrich to the company's board of directors.
Mr. Woodrich has also been elected Chairman of the Board's Audit Committee. Both executives bring to the board proven experience and expertise in the management and growth of medical device and biotechnology firms.
Mr. Pattison, the Company's President and Chief Operating Officer since May 2, 2005, has over thirty years experience with technology based, health- care companies serving both diagnostic and therapeutic market segments. During the 1970's he held several senior management positions with the medical diagnostic and device division of Corning Glass Works. After leaving Corning, Mr. Pattison was President of three start-up companies involved with innovative drug-delivery products. At the Infusaid Corporation during the 1980's, Mr. Pattison led the regulatory approval and commercialization of two unique medical products: the industry's first implantable pump and the first vascular access port. Most recently, Mr. Pattison negotiated the sale of Arrow International's drug delivery business to Johnson & Johnson and then joined J&J as Executive Director of Drug Delivery. Mr. Pattison has a Bachelor of Science degree from Cornell University, Ithaca NY.
Mr. Woodrich is President and CEO of Woodrich & Associates, Inc., a management consulting firm providing strategic services to the biotechnology industry. Mr. Woodrich has more than twenty five years of business experience in technology-based life science companies. Prior to founding Woodrich & Associates, Mr. Woodrich held several senior management positions with emerging growth biotechnology companies. Mr. Woodrich served from 1999 to 2004 as the Senior Vice President, Business Development for Therion Biologics Corporation, a privately held biopharmaceutical company. Previously, Mr. Woodrich served as Executive Vice President and Chief Operating Officer of CytoMed, Inc. from 1995 until its acquisition in 1999. From 1991 until its acquisition in 1995, Mr. Woodrich served as Senior Vice President, Finance and Administration, CFO and later as President and Director of Oculon Corporation.
Mr. Woodrich has served in financial management positions at Infinet, Inc., Applied bioTechnology, and Millipore Corporation. While serving as a Senior Accountant at Arthur Andersen & Co., Mr. Woodrich became a Certified Public Accountant. Mr. Woodrich has a Bachelor of Science degree from Rensselaer Polytechnic Institute and a Masters in Business Administration from the Harvard University Graduate School of Business Administration.
"We are very pleased Mr. Pattison and Woodrich join our company's Board of Directors," stated Steve Peltzman, Chairman and Chief Executive Officer. "We are truly fortunate to able to attract individuals of such quality, industry knowledge and business competence. These appointments greatly strengthen our Company's corporate governance capabilities and are consistent with our commitment to increase the number of outside, independent directors."
About Saliva Diagnostic Systems, Inc.
Saliva Diagnostic Systems is engaged in the development, manufacture and marketing of rapid immunoassay tests for the detection of sexually transmitted and other infectious diseases; in addition, the Company has developed and is marketing a product line of patented, oral-fluid collection devices. The Company's proprietary platforms provide significant customer benefits and competitive advantages as compared to similar products that are currently available. Improved accuracy, operator convenience, and reduced risk of infection from collecting and handling specimens, have been engineered into SDS products. All of our diagnostic tests are based on the same easy-to-use technology platform, thus facilitating the development of future products. Saliva Diagnostic System's technology provides a quick, accurate, portable, safe and cost-effective solution.
Saliva Diagnostic Systems, Inc.